US Edition
News about Eli Lilly
Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 342stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Eli Lilly News
Obesity · DenmarkNovo Nordisk A/S (NYSE:NVS) announced Thursday that it will advance subcutaneous and oral amycretin into phase 3 development in weight management. Amycretin is developed for subcutaneous and oral administration. The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities following end-of-phase 2 interactions for subcutaneous and oral amycretin in weight management. Novo Nordisk p…See the Story
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company - Novo Nordisk (NYSE:NVO)
57% Center coverage: 7 sources
OzempicEli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full month of being on offer in the South Asian country, which has the world’s third-highest number of obese people.See the Story
Lilly’s Obesity Drug Sales Rise 60% in India Amid Rising Demand
Coverage: 7 sources
Eli Lilly(Reuters) -Eli Lilly’s experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an early-stage study, an investor note by brokerage Cantor Fitzgerald showed on Friday. The 12-week result was published in an abstract ahead of the American Diabetes Association conference in Chicago, the brokerage said. Cantor analyst Prakhar Agrawal said the data on eloralintide looked strong in terms of weight l…See the Story
Eli Lilly’s experimental obesity drug shows over 11% weight loss in early trial
Coverage: 2 sources
Eli Lilly and Company (NYSE:LLY) Shares Sold by Founders Grove Wealth Partners LLC
100% Center coverage: 1 sources
Eli Lilly's SWOT analysis: stock poised for growth amid challenges in GLP-1 market - Finnoexpert
Eli Lilly Announces Associate Territory Manager Role in Cardiometabolic Pharmaceutical Sales in Washington, D.C.
Moderna to Test New COVID-19 Vaccine Against Placebo Amid Eli Lilly’s $870 Million Obesity Drug Development Deal
Eli Lilly Announces Pharmaceutical Sales Territory Manager Opening for GI Products in South Bend
Benzinga Bulls And Bears: Eli Lilly, Okto, McDonalds — And Israel-Iran Conflict Sparks Oil Surge Benzinga Bulls And Bears: Eli Lilly, Okto, McDonalds — And Israel-Iran Conflict Sparks Oil Surge - AppLovin (NASDAQ:APP), GameStop (NYSE:GME)
100% Center coverage: 1 sources
